Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) reported EPS (Basic) of -$3.25 for Q1 2026, down 24.52% year-over-year from -$4.31 in Q1 2025, and down 60.1% quarter-over-quarter from -$2.03 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 17 years of EPS (Basic) data on file, last reported at -$3.25 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$3.25, down 24.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$10.79 (up 14.57% YoY), and the FY2025 annual result was -$10.15, up 41.36% from the prior year.
- EPS (Basic) eased to -$3.25 in Q1 2026 per MDGL's latest filing, from -$2.03 in the prior quarter.
- Over five years, EPS (Basic) peaked at $2.0 in Q4 2024 and troughed at -$7.38 in Q1 2024.
- A 5-year average of -$4.0 and a median of -$4.23 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) soared 135.21% in 2024, then sank 201.5% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$4.98 in 2022, then retreated by 14.06% to -$5.68 in 2023, then soared by 135.21% to $2.0 in 2024, then slumped by 201.5% to -$2.03 in 2025, then plunged by 60.1% to -$3.25 in 2026.
- Business Quant data shows MDGL's EPS (Basic) at -$3.25 in Q1 2026, -$2.03 in Q4 2025, and -$4.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | -3.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.25 |
| Dec 31, 2025 | -2.03 |
| Sep 30, 2025 | -4.01 |
| Jun 30, 2025 | -1.50 |
| Mar 31, 2025 | -2.61 |
| Dec 31, 2024 | 2.00 |
| Sep 30, 2024 | -4.92 |
| Jun 30, 2024 | -7.10 |
| Mar 31, 2024 | -7.38 |
| Dec 31, 2023 | -5.68 |
| Sep 30, 2023 | -5.34 |
| Jun 30, 2023 | -4.69 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -4.98 |
| Sep 30, 2022 | -4.75 |
| Jun 30, 2022 | -4.14 |
| Mar 31, 2022 | -3.36 |
| Dec 31, 2021 | -3.78 |
| Sep 30, 2021 | -3.79 |
| Jun 30, 2021 | -3.72 |